{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:56:57Z","timestamp":1793300217238,"version":"4.5.0"},"reference-count":150,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Mucormycosis is an angio-invasive fungal infection, associated with high morbidity and mortality. A change in the epidemiology of mucormycosis has been observed in recent years with the rise in incidence, new causative agents and susceptible population. The rise has been perceived globally, but it is very high in the Asian continent. Though diabetes mellitus overshadow all other risk factors in Asia, post-tuberculosis and chronic renal failure have emerged as new risk groups. The rhino-cerebral form of mucormycosis is most commonly seen in patients with diabetes mellitus, whereas, pulmonary mucormycosis in patients with haematological malignancy and transplant recipients. In immunocompetent hosts, cutaneous mucormycosis is commonly seen following trauma. The intriguing clinical entity, isolated renal mucormycosis in immunocompetent patients is only reported from China and India. A new clinical entity, indolent mucormycosis in nasal sinuses, is recently recognized. The causative agents of mucormycosis vary across different geographic locations. Though Rhizopus arrhizus is the most common agent isolated worldwide, Apophysomyces variabilis is predominant in Asia and Lichtheimia species in Europe. The new causative agents, Rhizopus homothallicus, Mucor irregularis, and Thamnostylum lucknowense are reported from Asia. In conclusion, with the change in epidemiology of mucormycosis country-wise studies are warranted to estimate disease burden in different risk groups, analyse the clinical disease pattern and identify the new etiological agents.<\/jats:p>","DOI":"10.3390\/jof5010026","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T12:28:01Z","timestamp":1553171281000},"page":"26","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":734,"title":["Global Epidemiology of Mucormycosis"],"prefix":"10.3390","volume":"5","author":[{"given":"Hariprasath","family":"Prakash","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1555-3807","authenticated-orcid":false,"given":"Arunaloke","family":"Chakrabarti","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236","article-title":"Zygomycetes in Human Disease","volume":"13","author":"Ribes","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1469-0691.2009.02972.x","article-title":"The ecology of the Zygomycetes and its impact on environmental exposure","volume":"15","author":"Richardson","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: A review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Prakash, H., Ghosh, A.K., Rudramurthy, S.M., Singh, P., Xess, I., Savio, J., Pamidimukkala, U., Jillwin, J., Varma, S., and Das, A. (2018). A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment. Med. Mycol.","DOI":"10.1093\/mmy\/myy060"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/clinids\/27.5.1138","article-title":"The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992\u20131993: Results of population-based laboratory active surveillance","volume":"27","author":"Rees","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1128\/JCM.02473-06","article-title":"Impact of zygomycosis on microbiology workload: A survey study in Spain","volume":"45","author":"Guinea","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3201\/eid1509.090334","article-title":"Increasing incidence of zygomycosis (mucormycosis), France, 1997\u20132006","volume":"15","author":"Bitar","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/j.ijid.2009.11.024","article-title":"Emerging invasive zygomycosis in a tertiary care center: Epidemiology and associated risk factors","volume":"14","author":"Ambrosioni","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/13693780500464930","article-title":"The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus","volume":"44","author":"Chakrabarti","year":"2006","journal-title":"Med. Mycol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: Analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/cid\/cir867","article-title":"Healthcare-associated mucormycosis","volume":"54","author":"Rammaert","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3201\/eid1609.100276","article-title":"Increasing incidence of Mucormycosis in university hospital, Belgium","volume":"16","author":"Saegeman","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kontoyiannis, D.P., Yang, H., Song, J., Kelkar, S.S., Yang, X., Azie, N., Harrington, R., Fan, A., Lee, E., and Spalding, J.R. (2016). Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: A retrospective study. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-2023-z"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Guinea, J., Escribano, P., Vena, A., Mu\u00f1oz, P., Mart\u00ednez-Jim\u00e9nez, M.D.C., Padilla, B., and Bouza, E. (2017). Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179136"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/jinf.2001.0831","article-title":"Ten Years\u2019 Experience in Zygomycosis at a Tertiary Care Centre in India","volume":"42","author":"Chakrabarti","year":"2001","journal-title":"J. Infect."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/pgmj.2008.076463","article-title":"Invasive zygomycosis in India: Experience in a tertiary care hospital","volume":"85","author":"Chakrabarti","year":"2009","journal-title":"Postgrad. Med. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s15010-017-0991-6","article-title":"Pulmonary mucormycosis: Clinical features and outcomes","volume":"45","author":"Lin","year":"2017","journal-title":"Infection"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/myc.12081","article-title":"Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: A 20-year autopsy study","volume":"56","author":"Lewis","year":"2013","journal-title":"Mycoses"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcrc.2019.02.005","article-title":"Epidemiology and clinical outcomes of invasive mould infections in Indian intensive care units (FISF study)","volume":"5","author":"Chakrabarti","year":"2019","journal-title":"J. Crit. Care"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.mycmed.2018.02.014","article-title":"Mucormycosis in Iran: A six-year retrospective experience","volume":"28","author":"Dolatabadi","year":"2018","journal-title":"J. Mycol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1128\/JCM.37.6.1732-1738.1999","article-title":"Epidemiology of visceral mycoses: Analysis of data in Annual of the Pathological Autopsy Cases in Japan","volume":"37","author":"Yamazaki","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Bongomin, F., Gago, S., Oladele, R., and Denning, D. (2017). Global and Multi-National Prevalence of Fungal Diseases\u2014Estimate Precision. J. Fungi, 3.","DOI":"10.3390\/jof3040057"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12281-013-0152-z","article-title":"Epidemiology of mucormycosis in India","volume":"7","author":"Chakrabarti","year":"2013","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10096-017-2917-8","article-title":"Burden of fungal infections in Algeria","volume":"36","author":"Denning","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Riera, F., Caeiro, J., and Denning, D. (2018). Burden of Serious Fungal Infections in Argentina. J. Fungi, 4.","DOI":"10.3390\/jof4020051"},{"key":"ref_27","unstructured":"Chen, S.A., Slavin, M.A., Marriott, D., Thursky, K., Denning, D., Sorrell, T.C., and Sorrell, T. (2019, January 31). Burden of Serious Fungal Infections in Australia. Available online: http:\/\/life-worldwide.org\/assets\/uploads\/files\/ICAAC%20poster%20burdenaustralia.pdf."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/myc.12389","article-title":"Burden of serious fungal infections in Belgium","volume":"58","author":"Lagrou","year":"2015","journal-title":"Mycoses"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/myc.12427","article-title":"The burden of serious human fungal infections in Brazil","volume":"59","author":"Giacomazzi","year":"2016","journal-title":"Mycoses"},{"key":"ref_30","unstructured":"Aspergillus & Aspergillosis Website (2019, January 31). The Burden of Severe Human Fungal Infections in Brazil. Available online: https:\/\/www.aspergillus.org.uk\/content\/burden-severe-human-fungal-infections-brazil."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Mandengue, C., and Denning, D. (2018). The Burden of Serious Fungal Infections in Cameroon. J. Fungi, 4.","DOI":"10.3390\/jof4020044"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s10096-017-2922-y","article-title":"Serious fungal infections in Canada","volume":"36","author":"Dufresne","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_33","unstructured":"Dufresne, S.F., Sheppard, D.C., and Denning, D.W. (2015, January 4\u20138). Estimating the Burden of Serious Fungal Diseases in Canada. Proceedings of the International Society of Human and Animal Mycology (ISHAM), Melbourne, Australia."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10096-017-2925-8","article-title":"Serious fungal infections in Chile","volume":"36","author":"Denning","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Alvarez-Moreno, C.A., Cortes, J.A., and Denning, D.W. (2018). Burden of Fungal Infections in Colombia. J. Fungi, 4.","DOI":"10.3390\/jof4020041"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/myc.12384","article-title":"Burden of serious fungal infections in the Czech Republic","volume":"58","author":"Chrdle","year":"2015","journal-title":"Mycoses"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/myc.12383","article-title":"The burden of fungal disease in Denmark","volume":"58","author":"Mortensen","year":"2015","journal-title":"Mycoses"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jiph.2015.04.026","article-title":"Burden of serious fungal infections in the Dominican Republic","volume":"9","author":"Gugnani","year":"2016","journal-title":"J. Infect. Public Health"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.mycmed.2016.11.001","article-title":"An estimation of burden of serious fungal infections in France","volume":"26","author":"Gangneux","year":"2016","journal-title":"J. Mycol. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s10096-016-2642-8","article-title":"An estimate of the burden of serious fungal diseases in Greece","volume":"35","author":"Gamaletsou","year":"2016","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1099\/jmm.0.000020","article-title":"Burden of fungal disease in Ireland","volume":"64","author":"Dorgan","year":"2015","journal-title":"J. Med. Microbiol."},{"key":"ref_42","unstructured":"Aspergillus & Aspergillosis Website (2019, January 30). The Burden of Serious Fungal Diseases in Japan. Available online: https:\/\/www.aspergillus.org.uk\/content\/burden-serious-fungal-diseases-japan."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Wadi, J., and Denning, D. (2018). Burden of Serious Fungal Infections in Jordan. J. Fungi, 4.","DOI":"10.3390\/jof4010015"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Kemaykin, V., Tabinbaev, N., Khudaibergenova, M., Olifirovich, A., Abdrakhmanova, L., Denning, D., and Klimko, N. (2018). An Estimate of Severe and Chronic Fungal Diseases in the Republic of Kazakhstan. J. Fungi, 4.","DOI":"10.3390\/jof4010034"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3855\/jidc.7614","article-title":"Estimated burden of fungal infections in Kenya","volume":"10","author":"Guto","year":"2016","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s10096-017-2923-x","article-title":"Serious fungal infections in Korea","volume":"36","author":"Huh","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Kalua, K., Zimba, B., and Denning, D. (2018). Estimated Burden of Serious Fungal Infections in Malawi. J. Fungi, 4.","DOI":"10.3390\/jof4020061"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/myc.12394","article-title":"Burden of serious fungal infections in Mexico","volume":"58","author":"Denning","year":"2015","journal-title":"Mycoses"},{"key":"ref_49","first-page":"107","article-title":"Burden of Serious Fungal Infection in Nigeria","volume":"33","author":"Denning","year":"2014","journal-title":"West Afr. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Nord\u00f8y, I., Hesstvedt, L., Torp Andersen, C., Mylvaganam, H., Kols, N., Falch, B., Tofteland, S., M\u00fcller, F., and Denning, D. (2018). An Estimate of the Burden of Fungal Disease in Norway. J. Fungi, 4.","DOI":"10.3390\/jof4010029"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10096-017-2919-6","article-title":"Serious fungal infections in Pakistan","volume":"36","author":"Jabeen","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s10096-017-2918-7","article-title":"Serious fungal infections in the Philippines","volume":"36","author":"Batac","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s10096-017-2930-y","article-title":"Serious fungal infections in Portugal","volume":"36","author":"Sabino","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/myc.12386","article-title":"Burden of fungal infections in Qatar","volume":"58","author":"Chandra","year":"2015","journal-title":"Mycoses"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Mare\u0219, M., Moroti-Constantinescu, V., and Denning, D. (2018). The Burden of Fungal Diseases in Romania. J. Fungi, 4.","DOI":"10.20944\/preprints201802.0137.v1"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/myc.12388","article-title":"The burden of serious fungal diseases in Russia","volume":"58","author":"Klimko","year":"2015","journal-title":"Mycoses"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Arsenijevi\u0107, V., and Denning, D. (2018). Estimated Burden of Serious Fungal Diseases in Serbia. J. Fungi, 4.","DOI":"10.3390\/jof4030076"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1128\/AAC.00383-13","article-title":"Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP study)","volume":"57","author":"Mellado","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10096-017-2927-6","article-title":"Serious fungal infections in Thailand","volume":"36","author":"Chayakulkeeree","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/myc.12409","article-title":"Burden of serious fungal infections in Ukraine","volume":"58","author":"Osmanov","year":"2015","journal-title":"Mycoses"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jinf.2016.10.005","article-title":"Estimating the burden of invasive and serious fungal disease in the United Kingdom","volume":"74","author":"Pegorie","year":"2017","journal-title":"J. Infect."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"ofy187","DOI":"10.1093\/ofid\/ofy187","article-title":"Epidemiology and Clinical Features of Invasive Fungal Infection in a US Health Care Network","volume":"5","author":"Webb","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10096-017-2926-7","article-title":"Serious fungal diseases in the Republic of Uzbekistan","volume":"36","author":"Tilavberdiev","year":"2017","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1469-0691.2009.02973.x","article-title":"Changing epidemiology of an emerging infection: Zygomycosis","volume":"15","author":"Meis","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_65","first-page":"231","article-title":"Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes","volume":"51","author":"Nithyanandam","year":"2003","journal-title":"Indian J. Ophthalmol."},{"key":"ref_66","first-page":"73","article-title":"Mucormycosis in Cairo, Egypt: Review of 10 reported cases","volume":"52","author":"Zaki","year":"2014","journal-title":"Med. Mycol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/pgmj.2003.016030","article-title":"Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes","volume":"80","author":"Bhansali","year":"2004","journal-title":"Postgrad. Med. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/512817","article-title":"Decrease in the Number of Reported Cases of Zygomycosis among Patients with Diabetes Mellitus: A Hypothesis","volume":"44","author":"Kontoyiannis","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/mmy\/myx017","article-title":"Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases","volume":"56","author":"Walsh","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/cid\/cir880","article-title":"A global analysis of mucormycosis in France: The RetroZygo study (2005\u20132007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1179\/joc.2009.21.3.322","article-title":"Zygomycosis in Italy: A survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology)","volume":"21","author":"Pagano","year":"2009","journal-title":"J. Chemother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10096-003-1035-y","article-title":"Mucormycosis: Ten-Year Experience at a Tertiary-Care Center in Greece","volume":"22","author":"Petrikkos","year":"2003","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_74","first-page":"207","article-title":"Mucormycosis in hematologic patients","volume":"89","author":"Pagano","year":"2004","journal-title":"Haematologica"},{"key":"ref_75","first-page":"296","article-title":"Forty-one recent cases of invasive zygomycosis from a global clinical registry","volume":"65","author":"Heinz","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"E396","DOI":"10.1111\/j.1469-0691.2012.03908.x","article-title":"Mucormycosis after allogeneic haematopoietic stem cell transplantation: A French Multicentre Cohort Study (2003\u20132008)","volume":"18","author":"Xhaard","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/522189","article-title":"Fungal Infections in Recipients of Hematopoietic Stem Cell Transplants: Results of the SEIFEM B-2004 Study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne","volume":"45","author":"Pagano","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3201\/eid1710.110087","article-title":"Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001\u20132006","volume":"17","author":"Park","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001\u20132006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3906\/sag-1409-137","article-title":"Mucormycosis: A 10-year experience at a tertiary care center in Turkey","volume":"46","author":"Kurtaran","year":"2016","journal-title":"Turk. J. Med. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/j.1600-6143.2006.01496.x","article-title":"Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature","volume":"6","author":"Almyroudis","year":"2006","journal-title":"Am. J. Transplant."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1086\/605445","article-title":"Zygomycosis in Solid Organ Transplant Recipients: A Prospective, Matched Case-Control Study to Assess Risks for Disease and Outcome","volume":"200","author":"Singh","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1288\/00005537-198910000-00006","article-title":"Rhinocerebral mucormycosis: Predisposing factors","volume":"92","author":"McNulty","year":"1982","journal-title":"Laryngoscope"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cmi.2016.01.005","article-title":"Mucormycosis in Australia: Contemporary epidemiology and outcomes","volume":"22","author":"Kennedy","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1172\/JCI116419","article-title":"Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies","volume":"91","author":"Boelaert","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0272-6386(12)80606-8","article-title":"Deferoxamine Therapy and Mucormycosis in Dialysis Patients: Report of an International Registry","volume":"18","author":"Boelaert","year":"1991","journal-title":"Am. J. Kidney Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1128\/AAC.00361-09","article-title":"Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosis","volume":"53","author":"Spellberg","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"7765","DOI":"10.4081\/idr.2018.7765","article-title":"Deferiprone as adjunctive treatment for patients with invasive mucormycosis: A retrospective case series","volume":"10","author":"Chitasombat","year":"2018","journal-title":"Infect. Dis. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The Deferasirox\u2013AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: A randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_91","first-page":"1621","article-title":"Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions","volume":"67","author":"Lionakis","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: A single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/422723","article-title":"Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis","volume":"39","author":"Siwek","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/00365540410019408","article-title":"Two case reports: Fatal absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial absidia corymbifera colonization in a lung transplant patient","volume":"36","author":"Mattner","year":"2004","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a Tertiary-Care Cancer Center in the Era of Aspergillus- Active Antifungal Therapy: A Case-Control Observational Study of 27 Recent Cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bmt.1705614","article-title":"Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy","volume":"39","author":"Trifilio","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/jac\/dks189","article-title":"Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: Real-life data from a single-centre institutional retrospective observational study","volume":"67","author":"Auberger","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/myc.12357","article-title":"Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: A single-centre retrospective study in Korea and clinical considerations","volume":"58","author":"Cho","year":"2015","journal-title":"Mycoses"},{"key":"ref_100","first-page":"O952","article-title":"Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: A 4-year study","volume":"20","author":"Lerolle","year":"2014","journal-title":"Eur. Soc. Clin. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/ofid\/ofw172.1280","article-title":"Breakthrough Invasive Fungal Infections in Patients with Hematologic Malignancy (HM) and Hematopoietic Cell Transplantation (HCT) Receiving Isavuconazole for Empiric or Directed Antifungal Therapy","volume":"3","author":"Dadwal","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/cid\/ciy260","article-title":"Breakthrough Invasive Fungal Infections on Isavuconazole Prophylaxis and Treatment: What Is Happening in the Real-World Setting?","volume":"67","author":"Fung","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_103","first-page":"1610","article-title":"Breakthrough Fungal Infections in Patients with Leukemia Receiving Isavuconazole","volume":"67","author":"Rausch","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jinf.2011.12.015","article-title":"Breakthrough invasive mould infections in patients treated with caspofungin","volume":"64","author":"Godet","year":"2012","journal-title":"J. Infect."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation","volume":"39","author":"Ratanatharathorn","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1592\/phco.27.12.1644","article-title":"Caspofungin as Primary Antifungal Prophylaxis in Stem Cell Transplant Recipients","volume":"27","author":"Chou","year":"2007","journal-title":"Pharmacotherapy"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.idcr.2018.03.017","article-title":"Fatal breakthrough mucormycosis in a multivisceral transplant patient receiving micafungin: Case report and literature review","volume":"12","author":"Micallef","year":"2018","journal-title":"IDCases"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jinf.2016.06.013","article-title":"The burden of mucormycosis in HIV-infected patients: A systematic review","volume":"73","author":"Moreira","year":"2016","journal-title":"J. Infect."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/EC.00138-13","article-title":"The calcineurin pathway inhibitor tacrolimus enhances the in vitro activity of azoles against Mucorales via apoptosis","volume":"12","author":"Shirazi","year":"2013","journal-title":"Eukaryot. Cell"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/jac\/dkr297","article-title":"In vitro interaction of caspofungin and immunosuppressives against agents of mucormycosis","volume":"66","author":"Thakur","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/infdis\/jis767","article-title":"Tacrolimus Enhances the Potency of Posaconazole Against Rhizopus oryzae In Vitro and in an Experimental Model of Mucormycosis","volume":"207","author":"Lewis","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/13693780500338951","article-title":"Primary renal zygomycosis due to Rhizopus oryzae","volume":"44","author":"Yu","year":"2006","journal-title":"Med. Mycol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1469-0691.2009.02982.x","article-title":"Outbreaks of zygomycosis in hospitals Definition of a Hospital Outbreak","volume":"15","author":"Antoniadou","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/BF03017426","article-title":"Primary cutaneous mucormycosis complicating the use of adhesive tape to secure the endotracheal tube","volume":"49","author":"Alsuwaida","year":"2002","journal-title":"Can. J. Anesth."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0195-6701(98)90064-0","article-title":"Rhizopus microsporus in wooden tongue depressors: A major threat or minor inconvenience?","volume":"38","author":"Holzel","year":"1998","journal-title":"J. Hosp. Infect."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0140-6736(96)05059-3","article-title":"Nosocomial infection with Rhizopus microsporus in preterm infants: Association with wooden tongue depressors","volume":"348","author":"Mitchell","year":"1996","journal-title":"Lancet"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1128\/jcm.35.9.2422-2423.1997","article-title":"Wooden sticks as the source of a pseudoepidemic of infection with Rhizopus microsporus var. rhizopodiformis among immunocompromised patients","volume":"35","author":"Verweij","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/508277","article-title":"Outbreak of cutaneous Rhizopus arrhizus infection associated with karaya ostomy bags","volume":"43","author":"Burwell","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jhin.2004.12.011","article-title":"An outbreak of Absidia corymbifera infection associated with bandage contamination in a burns unit","volume":"61","author":"Christiaens","year":"2005","journal-title":"J. Hosp. Infect."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1128\/JCM.00908-09","article-title":"Outbreak of intestinal infection due to Rhizopus microsporus","volume":"47","author":"Cheng","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/INF.0000000000000261","article-title":"Mucormycosis Outbreak Associated with Hospital Linens","volume":"33","author":"Duffy","year":"2014","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination Polyene-Caspofungin Treatment of Rhino-Orbital-Cerebral Mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/coa.13175","article-title":"A meta-analysis of survival factors in rhino-orbital-cerebral mucormycosis\u2014has anything changed in the past 20 years?","volume":"43","author":"Vaughan","year":"2018","journal-title":"Clin. Otolaryngol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0039-6257(05)80041-4","article-title":"Survival factors in rhino-orbital-cerebral mucormycosis","volume":"39","author":"Yohai","year":"1994","journal-title":"Surv. Ophthalmol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/TP.0b013e3181dde8fc","article-title":"Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients","volume":"90","author":"Sun","year":"2010","journal-title":"Transplantation"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jiph.2012.01.003","article-title":"Cerebro-rhino orbital mucormycosis: An update","volume":"5","author":"Wali","year":"2012","journal-title":"J. Infect. Public Health"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejrnm.2018.01.001","article-title":"Imaging features of rhinocerebral mucormycosis: A study of 43 patients","volume":"49","author":"Therakathu","year":"2018","journal-title":"Egypt. J. Radiol. Nucl. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0003-4975(94)90243-7","article-title":"Pulmonary mucormycosis: Results of medical and surgical therapy","volume":"57","author":"Tedder","year":"1994","journal-title":"Ann. Thorac. Surg."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.159.12.1301","article-title":"Pulmonary mucormycosis: The last 30 years","volume":"159","author":"Lee","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s15010-018-1149-x","article-title":"Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome","volume":"46","author":"Feng","year":"2018","journal-title":"Infection"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.clindermatol.2012.01.010","article-title":"Global epidemiology of cutaneous zygomycosis","volume":"30","author":"Skiada","year":"2012","journal-title":"Clin. Dermatol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1469-0691.2009.02979.x","article-title":"Cutaneous zygomycosis","volume":"15","author":"Skiada","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/00365540701840096","article-title":"Nosocomial post-traumatic cutaneous mucormycosis: A systematic review","volume":"40","author":"Simbli","year":"2008","journal-title":"Scand. J. Infect. Dis."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/myc.12798","article-title":"Gastrointestinal mucormycosis in apparently immunocompetent hosts\u2014A review","volume":"61","author":"Kaur","year":"2018","journal-title":"Mycoses"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/myc.12419","article-title":"Gastrointestinal mucormycosis in immunocompromised hosts","volume":"58","author":"Dioverti","year":"2015","journal-title":"Mycoses"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.ju.0000100842.96636.a0","article-title":"Isolated renal mucormycosis in children","volume":"171","author":"Jianhong","year":"2004","journal-title":"J. Urol."},{"key":"ref_138","first-page":"769","article-title":"Isolated bilateral renal mucormycosis in apparently immunocompetent patients\u2014a case series from India and review of the literature","volume":"11","author":"Bhadauria","year":"2018","journal-title":"Clin. Kidney J."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/CMR.00056-10","article-title":"Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species","volume":"24","author":"Gomes","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JCM.41.2.783-788.2003","article-title":"Apophysomyces elegans: An emerging zygomycete in India","volume":"41","author":"Chakrabarti","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/mmy\/myu086","article-title":"A prospective study of mucormycosis in north India: Experience from a tertiary care hospital","volume":"53","author":"Bala","year":"2015","journal-title":"Med. Mycol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e00433-18","DOI":"10.1128\/JCM.00433-18","article-title":"Emerging Rhizopus microsporus Infections in India","volume":"56","author":"Pandey","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/JCM.01272-09","article-title":"Cavitary pulmonary zygomycosis caused by Rhizopus homothallicus","volume":"48","author":"Chakrabarti","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s11046-017-0153-5","article-title":"Rhizopus homothallicus Causing Invasive Infections: Series of Three Cases from a Single Centre in North India","volume":"182","author":"Kokkayil","year":"2017","journal-title":"Mycopathologia"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s11046-017-0151-7","article-title":"Fatal Pulmonary Mucormycosis due to Rhizopus homothallicus","volume":"182","author":"Compain","year":"2017","journal-title":"Mycopathologia"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1128\/JCM.02326-10","article-title":"Chronic rhinofacial mucormycosis caused by Mucor irregularis (Rhizomucor variabilis) in India","volume":"49","author":"Hemashettar","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3767\/003158513X665539","article-title":"Taxonomy and epidemiology of Mucor irregularis, agent of chronic cutaneous mucormycosis","volume":"30","author":"Lu","year":"2013","journal-title":"Persoonia"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/13693786.2010.499521","article-title":"Two new species of Mucor from clinical samples","volume":"49","author":"Cano","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/JCM.06611-11","article-title":"Evidence implicating Thamnostylum lucknowense as an etiological agent of rhino-orbital mucormycosis","volume":"50","author":"Xess","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/mmy\/myw014","article-title":"The environmental source of emerging apophysomyces variabilis infection in India","volume":"54","author":"Prakash","year":"2016","journal-title":"Med. Mycol."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/5\/1\/26\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:39:40Z","timestamp":1760186380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/5\/1\/26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":150,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["jof5010026"],"URL":"https:\/\/doi.org\/10.3390\/jof5010026","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,21]]}}}